Scientific Reviews
Product Guides
Blogs
Topics
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!2025-02-06
23 Results for "
Bak BH3
" in MedChemExpress (MCE) Product Catalog:
Products (23)
23 Results for "Bak BH3" in MCE Product Catalog:
Cat. No.: HY-P0300
CAS No.: 300349-67-1
Target:
Research Areas:
77
77 Publications Verification
Cat. No.: HY-50907
CAS No.: 852808-04-9
Target:
Research Areas:
ABT-737, a BH3 mimetic, is a potent Bcl-2, Bcl-xL and Bcl-w inhibitor with EC50s of 30.3 nM, 78.7 nM, and 197.8 nM, respectively. ABT-737 induces the disruption of the BCL-2/BAX complex and BAK-dependent but BIM-independent activation of the intrinsic apoptotic pathway. ABT-737 induces autophagy and has the potential for acute myeloid leukemia (AML) research .
20
Category:
Alkaloids Plant Metabolic Disease Chelidonium majus Extract Disease Research Fields Isoquinoline Alkaloids Inflammation/Immunology Papaveraceae Extract
Target:
Cat. No.: HY-172262
Target:
Research Areas:
WEHI-3773 is a VDAC2 ligand and apoptosis modulator. WEHI-3773 directly binds to the β7-β10 region of VDAC2 and disrupts its interaction with BAX and BAK. WEHI-3773 regulates BAX-mediated apoptosis in BAK-deficient cells by modulating conformational activation of BAX, mitochondrial redistribution, and cytochrome c release. WEHI-3773 overcomes Venetoclax (HY-15531) resistance, resensitizes leukemia cells carrying BAX mutations to BH3 mimetics, and enables long-term clonogenic survival of BAK-deficient cells treated with BH3 mimetics. WEHI-3773 is applicable to research related to acute myeloid leukemia .
Cat. No.: HY-162858
CAS No.: 2329719-65-3
Target:
Research Areas:
BRD-810 is a potent and selective MCL1 inhibitor with a Kd of 0.3 nM. BRD-810 can specifically block the BH3 binding groove of MCL1, while having little effect on other anti-apoptotic proteins (such as Bcl-2, Bcl-xL). BRD-810 effectively destroys the MCL1-BAK complex (IC50 = 1.2 nM) in cancer cells, rapidly activates Caspase and induces cell apoptosis. BRD-810 can be used in the research of various cancers such as hematological tumors and solid tumors .
Cat. No.: HY-N2359
CAS No.: 34316-15-9
Category:
Alkaloids Plant Macleaya cordata (Willd.) R. Br. Extract Metabolic Disease Disease Research Fields Isoquinoline Alkaloids Inflammation/Immunology Papaveraceae Extract
Target:
Synonyms: BHI1
Target:
Research Areas:
BH3I-1 is a Bcl-2 family antagonist, which inhibits the binding of the Bak BH3 peptide to Bcl-xL with a Ki of 2.4±0.2 μM in FP assay. BH3I-1 has a Kd of 5.3 μM against the p53/MDM2 pair.
Cat. No.: HY-P1562
Target:
Research Areas:
Cat. No.: HY-P0300F
Target:
Research Areas:
Cat. No.: HY-P5325A
Target:
Research Areas:
Cat. No.: HY-P5325
CAS No.: 505070-05-3
Target:
Research Areas:
Cat. No.: HY-P10614
CAS No.: 300349-78-4
Target:
Research Areas:
Cat. No.: HY-P1562A
Target:
Research Areas:
Cat. No.: HY-161577
CAS No.: 701231-39-2
Target:
Research Areas:
BFC1103 is a small-molecule compound whose primary mechanism of action involves interaction with a specific domain of Bcl-2, particularly its loop domain. This interaction induces a conformational change in Bcl-2, exposing its BH3 (Bcl-2 homology 3) domain, thereby switching Bcl-2's function from anti-apoptotic to pro-apoptotic. The cell death induced by BFC1103 is dependent on the presence of Bax or Bak, both of which are key proteins involved in the intrinsic apoptotic pathway mediated by mitochondria. BFC1103 has successfully inhibited lung metastasis of triple-negative breast cancer in mouse models. It can be utilized in studying the roles of Bcl-2 family proteins in cancer development and how they impact the survival and proliferation of cancer cells .
Cat. No.: HY-W286906
CAS No.: 518303-27-0
Target:
Research Areas:
Mcl1-IN-15 (Compound 7) is the inhibitor for myeloid cell leukemia 1 (Mcl-1) with an IC50 of 8.73 μM. Mcl1-IN-15 inhibits Mcl1-BH3 peptide interaction, activates the Bak/Bax-mediated apoptosis and exhibits antitumor activity .
Cat. No.: HY-50907S
CAS No.: 1217686-68-4
Cat. No.: HY-P10614A
Target:
Research Areas:
Category:
Plant Terpenoids Verbenaceae Extract Lantana camaraLinn. Extract Pentacyclic Triterpenoids
Target:
- 1
- 2
-
-
Protocols
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!A suitable model is crucial in drug screening experiments. Organs can mimic the three-dimensional functional structure of internal organs, have similar spatial organization to corresponding organs, maintain some key characteristics, and reproduce some physiological functions. They are widely used for modeling and personalized drug screening physiological functions.2025-02-06
